{"id":"W1969523085","doi":"10.1586/ern.13.12","title":"Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance","year":2013,"lang":"en","type":"review","venue":"Expert Review of Neurotherapeutics","topic":"Reproductive System and Pregnancy","field":"Immunology and Microbiology","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Pharmacovigilance; Natalizumab; Medicine; Glatiramer acetate; Intensive care medicine; Fingolimod; Teriflunomide; Clinical trial; Disease; Mitoxantrone; Pregnancy; Multiple sclerosis; Drugs in pregnancy; Pharmacology; Drug; Psychiatry; Internal medicine; Fetus","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005368164,0.0006545697,0.002375669,0.001829789,0.0003547753,0.001949222,0.001500473,0.002484916,0.002321693],"category_scores_gemma":[0.006668795,0.0003202088,0.001193987,0.002103008,0.000837752,0.001939749,0.0008674221,0.002669391,0.0009214033],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001213191,"about_ca_system_score_gemma":0.004214115,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002626345,"about_ca_topic_score_gemma":0.003583112,"domain_scores_codex":[0.9981736,0.0007657207,0.0003351726,0.0001357455,0.0005126368,0.00007710733],"domain_scores_gemma":[0.9933991,0.004668038,0.0006732789,0.000101089,0.001020456,0.0001381151],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006547527,0.00004048768,0.0003033708,0.0207886,0.0001511046,0.0002630521,0.0001068512,0.0002463089,0.0003540768,0.004090121,0.02629056,0.9473],"study_design_scores_gemma":[0.00005345137,0.0001507596,0.001743688,0.02972574,0.0004317729,0.002574642,0.0003595861,0.0002371907,0.0004221071,0.007466346,0.9567849,0.00004975801],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005861156,0.9971324,0.0001389195,0.00213056,0.0001597199,0.000003908721,0.00001073738,0.00000497431,0.0003600835],"genre_scores_gemma":[0.0008186792,0.9976101,0.0004411499,0.000687634,0.0002705244,0.000009598985,0.00001592631,0.000001913577,0.000144508],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005368164,"threshold_uncertainty_score":0.02838987,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1442044626414005,"score_gpt":0.3855751333231084,"score_spread":0.2413706706817079,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}